|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| Choose application no.
|
|
| |
|
|
| Application no. and date | 16805792.5 (espacenet) (Federated) (European Patent Register), 20161201 | | Patent/reg. no. and date | DK/EP 3383385, 20200729 | | Publication date | 20181010 | | Priority no. and date | GB 201521217, 20151201 | | EP pub. no. and date |
EP 3383385 20181010 | | Effective date | | | Applicant/owner | Oncopeptides Innovation AB, Luntmakargatan 46
111 37 Stockholm, SE | | Applicant ref. no. | 161832 | | Inventor | LINDBERG, Jakob, c/o Oncopeptides AB
Västra Trädgårdsgatan 15
S-111 53 Stockholm, SE | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/223 (2006.01) , A61K 31/573 (2006.01) | | Title | Melflufen-doseringsregimer for cancer | | Int. application no. | EP2016079511 | | Int. publication no. | WO2017093443 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
